• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

恶性多发性硬化症:临床及人口统计学预后因素

Malignant multiple sclerosis: clinical and demographic prognostic factors.

作者信息

Hampshire-Araújo Fabrício, Bergmann Anke, Alvarenga Regina Maria Papais, Vasconcelos Cláudia Cristina Ferreira

机构信息

Universidade Federal do Estado do Rio de Janeiro, Departamento de Neurologia, Rio de Janeiro RJ, Brasil.

Instituto Nacional de Câncer, Rio de Janeiro RJ, Brasil.

出版信息

Arq Neuropsiquiatr. 2017 Mar;75(3):139-141. doi: 10.1590/0004-282X20170010.

DOI:10.1590/0004-282X20170010
PMID:28355319
Abstract

Patients with malignant multiple sclerosis (MMS) reach a significant level of disability within a short period of time (Expanded Disability Status Scale score of 6 within five years). The clinical profile and progression of the disease were analyzed in a Brazilian cohort of 293 patients. Twenty-five (8,53%) patients were found to have MMS and were compared with the remaining 268 (91,47%). Women, non-white patients, older age at disease onset, shorter intervals between the first attacks, and more attacks in the first two years of the disease were all more common in the MMS group. These findings could serve as prognostic factors when making therapeutic decisions.

摘要

恶性多发性硬化症(MMS)患者在短时间内(五年内扩展残疾状态量表评分为6)会达到严重残疾程度。对巴西一个由293名患者组成的队列中的疾病临床特征和进展进行了分析。发现25名(8.53%)患者患有MMS,并与其余268名(91.47%)患者进行了比较。女性、非白人患者、发病时年龄较大、首次发作之间的间隔较短以及疾病前两年发作次数较多在MMS组中更为常见。这些发现可作为治疗决策时的预后因素。

相似文献

1
Malignant multiple sclerosis: clinical and demographic prognostic factors.恶性多发性硬化症:临床及人口统计学预后因素
Arq Neuropsiquiatr. 2017 Mar;75(3):139-141. doi: 10.1590/0004-282X20170010.
2
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.科威特儿童期多发性硬化症的疾病进展:一项回顾性分析。
Pediatr Neurol. 2015 Dec;53(6):508-12. doi: 10.1016/j.pediatrneurol.2015.06.010. Epub 2015 Jun 17.
3
[Prognostics factors of renal failure in multiple sclerosis].[多发性硬化症中肾衰竭的预后因素]
Prog Urol. 2012 Dec;22(16):1026-32. doi: 10.1016/j.purol.2012.08.271. Epub 2012 Sep 16.
4
Longitudinal follow-up of "benign" multiple sclerosis at 20 years.“良性”多发性硬化症20年的纵向随访
Neurology. 2007 Feb 13;68(7):496-500. doi: 10.1212/01.wnl.0000253185.03943.66.
5
Multiple Sclerosis Severity Score: using disability and disease duration to rate disease severity.多发性硬化严重程度评分:利用残疾情况和病程来评估疾病严重程度。
Neurology. 2005 Apr 12;64(7):1144-51. doi: 10.1212/01.WNL.0000156155.19270.F8.
6
Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.约旦人群中早发型和成年型多发性硬化症的自然病史及预后特征比较。
Clin Neurol Neurosurg. 2007 Jan;109(1):32-7. doi: 10.1016/j.clineuro.2006.06.002. Epub 2006 Jul 25.
7
Is late-onset multiple sclerosis associated with a worse outcome?迟发性多发性硬化症是否与更差的预后相关?
Neurology. 2006 Sep 26;67(6):954-9. doi: 10.1212/01.wnl.0000237475.01655.9d.
8
Change in disability profile and quality of life in multiple sclerosis patients: a five-year longitudinal study using the Multiple Sclerosis Impact Profile (MSIP).多发性硬化症患者残疾状况和生活质量的变化:一项使用多发性硬化症影响量表(MSIP)的五年纵向研究。
Mult Scler. 2012 May;18(5):654-61. doi: 10.1177/1352458511423935. Epub 2011 Sep 30.
9
Age at disability milestones in multiple sclerosis.多发性硬化症中达到残疾里程碑的年龄。
Brain. 2006 Mar;129(Pt 3):595-605. doi: 10.1093/brain/awh714. Epub 2006 Jan 16.
10
Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.多发性硬化症中的残疾与预后:对行走能力及残疾抚恤金授予至关重要的人口统计学和临床变量
Mult Scler. 2001 Feb;7(1):59-65. doi: 10.1177/135245850100700110.

引用本文的文献

1
Predictive factors and treatment challenges in malignant progression of relapsing-remitting multiple sclerosis.复发缓解型多发性硬化症恶性进展的预测因素及治疗挑战
Heliyon. 2024 Feb 17;10(4):e26658. doi: 10.1016/j.heliyon.2024.e26658. eCollection 2024 Feb 29.
2
Determinants of disability development in patients with multiple sclerosis.多发性硬化症患者残疾发展的决定因素。
Arq Neuropsiquiatr. 2021 Jun;79(6):489-496. doi: 10.1590/0004-282X-ANP-2020-0338.
3
Autologous haematopoietic stem cell transplantation as a first-line disease-modifying therapy in patients with 'aggressive' multiple sclerosis.
自体造血干细胞移植作为“侵袭性”多发性硬化症患者的一线疾病修正治疗。
Mult Scler. 2021 Jul;27(8):1198-1204. doi: 10.1177/1352458520985238. Epub 2021 Feb 10.